Budgeting and Cost Management for Biotechnology Projects
Expert-defined terms from the Professional Certificate in Biotechnology Project Management course at London School of Planning and Management. Free to read, free to share, paired with a professional course.
Activity #
Based Costing (ABC) – related terms: cost driver, indirect cost. A method that assigns costs to activities based on their use of resources, then allocates those costs to products or projects. Example: Allocating laboratory equipment depreciation to each assay based on usage hours. Challenge: Identifying accurate cost drivers in complex biotech workflows.
Adjusted Budget – related terms #
contingency, variance. A revised budget that incorporates changes from scope adjustments, regulatory updates, or unexpected expenses. Example: Increasing the R&D budget after a new FDA guidance requires additional validation studies. Challenge: Maintaining stakeholder alignment while managing scope creep.
Allocation Rate – related terms #
overhead rate, cost pool. The percentage used to distribute indirect costs across cost objects. Example: Applying a 15% overhead allocation to all project labor costs. Challenge: Ensuring the rate reflects true resource consumption without overburdening project teams.
Baseline Budget – related terms #
project plan, reference point. The original approved budget against which performance is measured. Example: Using the baseline to track cost variance during a gene‑editing pilot. Challenge: Updating the baseline without losing historical comparability.
Benefit‑Cost Ratio (BCR) – related terms #
economic feasibility, ROI. A metric comparing the monetary benefits of a project to its costs; a BCR greater than 1 indicates economic viability. Example: A BCR of 1.8 For a new diagnostic platform suggests strong value. Challenge: Quantifying intangible benefits such as market reputation.
Break‑Even Analysis – related terms #
fixed cost, variable cost. Determines the point at which total revenues equal total costs, indicating no profit or loss. Example: Calculating the number of assay kits needed to cover manufacturing expenses. Challenge: Accounting for fluctuating raw material prices in biotech.
Capital Expenditure (CapEx) – related terms #
fixed asset, depreciation. Funds used to acquire, upgrade, or maintain long‑term assets such as bioreactors, cleanrooms, or analytical instruments. Example: Budgeting $5 million for a GMP‑compliant facility. Challenge: Forecasting long‑term depreciation and salvage values.
Cash Flow Forecast – related terms #
liquidity, working capital. Projection of cash inflows and outflows over a specific period, essential for ensuring project solvency. Example: Forecasting quarterly cash requirements for consumables and contract manufacturing. Challenge: Predicting timing of milestone payments from investors.
Cost Allocation Matrix – related terms #
RACI, responsibility chart. A table that maps cost categories to functional units or project phases, clarifying who bears each expense. Example: Assigning 30% of analytical costs to the development phase and 70% to validation. Challenge: Keeping the matrix current as team structures evolve.
Cost Avoidance – related terms #
risk mitigation, expense reduction. Strategies aimed at preventing future expenses rather than reducing existing ones. Example: Selecting a vendor with a proven low‑contamination track record to avoid costly re‑work. Challenge: Measuring avoided costs against baseline assumptions.
Cost Baseline – related terms #
budget, performance measurement. The approved version of the project budget, including time‑phased cost estimates, used for tracking cost performance. Example: A cost baseline that breaks down expenses by month for a three‑year cell‑therapy program. Challenge: Integrating change orders without distorting the baseline.
Cost Benefit Analysis (CBA) – related terms #
economic evaluation, net present value. A systematic approach to compare the costs and benefits of a project, often expressed in monetary terms. Example: Evaluating the introduction of a high‑throughput screening platform by comparing equipment costs to projected assay savings. Challenge: Assigning monetary values to regulatory compliance benefits.
Cost Driver – related terms #
activity, allocation base. A factor that influences the cost of an activity, used to allocate indirect costs accurately. Example: Using the number of PCR cycles as a driver for consumable costs. Challenge: Selecting drivers that truly reflect resource usage in multi‑step biotech protocols.
Cost Engineering – related terms #
value engineering, cost control. The application of engineering principles to optimize project costs while maintaining quality and performance. Example: Redesigning a downstream purification process to reduce resin usage without compromising yield. Challenge: Balancing cost reductions with regulatory compliance constraints.
Cost Estimation – related terms #
bottom‑up, parametric. The process of approximating the monetary resources needed to complete a project. Example: Using historical data to estimate the cost of a new CRISPR‑based assay development. Challenge: Limited historical data for novel technologies increase uncertainty.
Cost Management Plan – related terms #
project charter, governance. A document that outlines how costs will be planned, structured, monitored, and controlled throughout the project lifecycle. Example: A plan that defines thresholds for cost variance alerts and approval processes for budget changes. Challenge: Ensuring the plan is adhered to across geographically dispersed teams.
Cost of Quality (CoQ) – related terms #
prevention cost, failure cost. The sum of costs incurred to achieve product quality plus the costs resulting from quality failures. Example: Accounting for inspection, re‑work, and warranty expenses in a biopharma manufacturing project. Challenge: Quantifying intangible costs such as brand damage.
Cost Recovery – related terms #
reimbursement, cost sharing. The process of recouping expenses through sales, licensing, or grant reimbursements. Example: Recovering R&D costs through milestone payments from a partner biotech firm. Challenge: Aligning recovery timelines with cash‑flow needs.
Cost Risk Register – related terms #
risk register, mitigation plan. A log that records identified cost‑related risks, their probability, impact, and mitigation strategies. Example: Documenting the risk of a supply chain disruption for a critical enzyme. Challenge: Keeping the register up‑to‑date as new risks emerge.
Cost Savings – related terms #
efficiency, lean. Reductions in expenses achieved through process improvements, negotiations, or technology adoption. Example: Negotiating bulk discounts for nucleic‑acid reagents to lower per‑sample costs. Challenge: Ensuring savings do not compromise experimental integrity.
Cost Variance (CV) – related terms #
Earned Value Management, performance index. The difference between earned value and actual cost; a negative CV indicates overruns. Example: A CV of –$150 k after six months of a protein‑production project. Challenge: Interpreting variance in the context of scientific uncertainty.
Critical Path Method (CPM) – related terms #
schedule, dependencies. A technique that identifies the longest sequence of dependent activities, determining the shortest possible project duration. Example: Using CPM to pinpoint the sequencing of cell line development, scale‑up, and clinical batch release. Challenge: Integrating cost constraints with schedule flexibility.
Cumulative Cost – related terms #
total spend, expense tracking. The aggregate amount spent on a project up to a specific point in time. Example: Reporting cumulative cost at each project phase gate to senior management. Challenge: Reconciling cumulative cost with multi‑currency expenditures.
Decentralized Budgeting – related terms #
organizational structure, autonomy. A budgeting approach where individual departments or business units control their own budgets, often leading to faster decision‑making. Example: A biotech subsidiary managing its own R&D budget for niche therapeutic areas. Challenge: Ensuring alignment with corporate financial objectives.
Depreciation – related terms #
capital asset, amortization. The systematic allocation of a capital asset’s cost over its useful life. Example: Straight‑line depreciation of a $2 million chromatography system over five years. Challenge: Selecting appropriate depreciation methods for tax and reporting purposes.
Direct Cost – related terms #
labor, material. Expenses that can be directly attributed to a specific project, such as reagents, salaries of dedicated scientists, and equipment usage. Example: The cost of a custom antibody produced for a target validation study. Challenge: Distinguishing direct from indirect costs in shared‑facility environments.
Earned Value Management (EVM) – related terms #
performance measurement, schedule variance. A methodology that integrates scope, schedule, and cost data to assess project performance and forecast outcomes. Example: Calculating a Schedule Performance Index (SPI) of 0.95 And a Cost Performance Index (CPI) of 1.10 For a gene‑therapy development project. Challenge: Obtaining accurate earned value data in research‑intensive settings.
Escalation Clause – related terms #
inflation, contract. A provision in a contract that allows for price adjustments based on inflation or other cost‑increase factors. Example: A clause that raises reagent prices by 3% annually. Challenge: Negotiating clauses that protect both supplier and buyer interests.
Fixed Cost – related terms #
overhead, sunk cost. Expenses that remain constant regardless of production volume, such as facility rent, salaries of permanent staff, and equipment depreciation. Example: The annual lease for a GMP cleanroom. Challenge: Allocating fixed costs fairly across multiple concurrent projects.
Funding Source – related terms #
grant, venture capital. The origin of financial resources for a project, which may include government grants, private investors, corporate budgets, or philanthropic donations. Example: Securing a $3 million grant from the National Institutes of Health for a vaccine platform. Challenge: Meeting differing reporting and compliance requirements for each source.
Funded Project – related terms #
budgeted, financed. A project that has secured the necessary financial resources to proceed. Example: A funded project to develop a biosimilar monoclonz for a rare disease. Challenge: Maintaining funding continuity throughout multi‑year development cycles.
Gantt Chart – related terms #
timeline, visualization. A bar‑chart representation of a project schedule, showing start and finish dates of elements. Example: Using a Gantt chart to visualize overlapping tasks in a cell‑line engineering timeline. Challenge: Integrating cost data into the visual representation.
Gross Margin – related terms #
profitability, revenue. The difference between revenue and cost of goods sold (COGS), expressed as a percentage of revenue. Example: A 45% gross margin for a recombinant protein sold to academic labs. Challenge: Sustaining margin while scaling production and meeting regulatory standards.
Indirect Cost – related terms #
overhead, support services. Expenses that cannot be directly linked to a single project, such as utilities, administrative salaries, and shared equipment maintenance. Example: Allocating 20% of the laboratory’s electricity bill across all active research projects. Challenge: Ensuring equitable distribution without inflating project budgets.
Inflation Adjustment – related terms #
price index, cost escalation. Modifying budget estimates to reflect anticipated changes in price levels over time. Example: Applying a 2.5% Annual inflation factor to consumable costs for a five‑year development plan. Challenge: Accurately forecasting inflation in volatile markets.
Initial Investment – related terms #
seed capital, upfront cost. The amount of money required to start a project, often covering equipment purchase, facility upgrades, and initial staffing. Example: An initial investment of $10 million to launch a new bioprocessing line. Challenge: Justifying the investment to stakeholders based on projected returns.
Internal Rate of Return (IRR) – related terms #
discount rate, profitability index. The discount rate at which the net present value (NPV) of cash flows equals zero; a key indicator of investment attractiveness. Example: An IRR of 18% for a gene‑editing platform suggests strong potential. Challenge: Calculating IRR when cash flows are irregular due to regulatory milestones.
Investment Appraisal – related terms #
feasibility study, NPV. The systematic evaluation of the financial merits of a project before committing resources. Example: Performing an investment appraisal that includes NPV, IRR, and payback period for a new bioreactor. Challenge: Incorporating scientific risk into financial models.
Labor Burden Rate – related terms #
fringe benefits, payroll. The multiplier applied to base salaries to account for taxes, benefits, and other employment costs. Example: A labor burden rate of 1.35 Applied to a senior scientist’s salary. Challenge: Updating rates to reflect changes in labor legislation.
Lifecycle Costing – related terms #
total cost of ownership, TCO. An approach that considers all costs associated with a product or asset from acquisition through disposal. Example: Evaluating the lifecycle cost of a bioreactor, including purchase, maintenance, energy, and decommissioning. Challenge: Projecting long‑term operating costs in fast‑changing technology landscapes.
Milestone Payment – related terms #
contractual deliverable, tranche. A scheduled payment tied to the successful completion of predefined project milestones. Example: Receiving a $500 k payment upon submission of an IND (Investigational New Drug) application. Challenge: Aligning milestone definitions with realistic timelines and cost estimates.
Net Present Value (NPV) – related terms #
discounted cash flow, profitability. The sum of present values of incoming and outgoing cash flows over a project's life; positive NPV indicates financial viability. Example: An NPV of $2 million for a biosensor development project calculated using a 10% discount rate. Challenge: Selecting appropriate discount rates for biotech risk profiles.
Operating Expense (OpEx) – related terms #
variable cost, day‑to‑day. Ongoing costs required for the day‑to‑day functioning of a project, such as consumables, utilities, and staff salaries. Example: Monthly OpEx of $250 k for a cell‑culture laboratory. Challenge: Controlling OpEx while maintaining high‑throughput capabilities.
Overhead Allocation – related terms #
indirect cost rate, shared services. The process of distributing overhead costs across projects based on a chosen allocation base. Example: Allocating 12% of total facility overhead to each active research project. Challenge: Ensuring allocation bases reflect actual resource consumption.
Pareto Analysis – related terms #
80/20 rule, cost reduction. A technique that identifies the most significant factors contributing to a problem, often visualized in a Pareto chart. Example: Discovering that 80% of cost overruns stem from three key suppliers. Challenge: Addressing root causes without disrupting critical supply chains.
Payback Period – related terms #
return horizon, investment recovery. The time required for cumulative cash inflows to equal the initial investment. Example: A 3‑year payback period for a high‑throughput screening platform. Challenge: Ignoring cash‑flow timing nuances that affect project risk.
Performance Measurement Baseline (PMB) – related terms #
EVM, cost baseline. The integrated scope, schedule, and cost baseline used for performance tracking. Example: Establishing a PMB that includes monthly cost targets for a vaccine development program. Challenge: Maintaining baseline integrity when scope changes occur.
Phased Funding – related terms #
stage‑gate, tranche. A financing approach where funds are released in stages upon meeting predefined criteria. Example: Receiving the second tranche after successful pre‑clinical toxicology results. Challenge: Aligning project pacing with funding release schedules.
Process Validation – related terms #
GMP, qualification. The documented evidence that a process consistently produces a product meeting its specifications. Example: Validating a downstream purification process to demonstrate batch‑to‑batch consistency. Challenge: Budgeting for extensive validation activities required by regulatory agencies.
Project Cost Management – related terms #
budgeting, cost control. The collection of processes required to ensure the project is completed within approved budget. Example: Integrating cost forecasting, monitoring, and variance analysis for a CRISPR‑based therapeutic project. Challenge: Balancing cost control with scientific flexibility.
Project Funding Model – related terms #
capital structure, financing mix. The framework describing how a project’s financial needs will be met, including equity, debt, and grants. Example: A hybrid model combining venture capital, government subsidies, and corporate R&D funds. Challenge: Coordinating disparate reporting requirements across funding sources.
Project Management Office (PMO) – related terms #
governance, standards. An organizational entity that defines and maintains project management standards, including budgeting practices. Example: A PMO that provides templates for cost estimation and variance reporting in biotech initiatives. Challenge: Ensuring PMO guidance adapts to rapidly evolving scientific methods.
Project Schedule – related terms #
timeline, critical path. A detailed plan that outlines when project activities will be performed. Example: A schedule that aligns DNA synthesis, clone screening, and scale‑up activities over 18 months. Challenge: Integrating schedule changes with cost re‑forecasting.
Quality Assurance (QA) Cost – related terms #
compliance, inspection. Expenses associated with maintaining product and process quality, including audits, documentation, and training. Example: Budgeting $200 k annually for internal QA audits of a biologics manufacturing line. Challenge: Quantifying the cost of preventing non‑compliance events.
Rate of Return (RoR) – related terms #
profitability, yield. The gain or loss on an investment relative to its cost, expressed as a percentage. Example: A 12% RoR on a new assay platform after three years of sales. Challenge: Differentiating RoR from IRR when cash flows are irregular.
Resource Loading – related terms #
capacity planning, utilization. Assigning resources (people, equipment) to project tasks, often visualized in a histogram. Example: Loading a skilled bioinformatician at 80% capacity across multiple data‑analysis tasks. Challenge: Avoiding overallocation that leads to schedule delays and cost overruns.
Return on Investment (ROI) – related terms #
benefit‑cost ratio, profitability. A measure of the financial gain relative to the investment cost, often expressed as a percentage. Example: Achieving a 150% ROI after commercializing a novel enzyme. Challenge: Incorporating long‑term regulatory costs into ROI calculations.
Risk Contingency – related terms #
reserve, uncertainty. An amount set aside to address identified risks that may affect cost or schedule. Example: A 5% contingency reserve for potential delays in raw material qualification. Challenge: Determining appropriate contingency levels without inflating budgets.
Risk Management Plan – related terms #
risk register, mitigation. A document that outlines how project risks will be identified, analyzed, and mitigated. Example: A plan that specifies monitoring of supply‑chain disruptions and associated cost impacts. Challenge: Ensuring the plan remains dynamic as new scientific risks emerge.
Resource Cost Rate – related terms #
hourly rate, labor cost. The cost assigned to a resource per unit of time, including salary, benefits, and overhead. Example: A resource cost rate of $120 per hour for a senior process engineer. Challenge: Updating rates to reflect market salary changes.
Revenue Forecast – related terms #
sales projection, market analysis. An estimate of future income based on market demand, pricing, and sales strategy. Example: Projecting $8 million in revenue over five years for a novel diagnostic kit. Challenge: Accounting for regulatory approval timelines that affect market entry.
Scope Creep – related terms #
change request, uncontrolled expansion. The uncontrolled growth of project scope without corresponding adjustments to time, cost, or resources. Example: Adding additional biomarker assays after initial project approval, leading to budget overruns. Challenge: Implementing strict change‑control processes to limit scope creep.
Schedule Performance Index (SPI) – related terms #
EVM, time efficiency. A ratio of earned value to planned value; values above 1 indicate ahead of schedule. Example: An SPI of 0.92 Suggests the project is behind schedule. Challenge: Interpreting SPI in research environments where task durations are inherently variable.
Scope Management Plan – related terms #
WBS, change control. A document that defines how project scope will be defined, validated, and controlled. Example: A plan that outlines deliverables for a gene‑therapy vector development project. Challenge: Balancing scientific discovery opportunities with budget constraints.
Scientific Cost Modeling – related terms #
parametric estimate, activity‑based. The use of scientific data and activity metrics to predict project costs. Example: Modeling the cost per genome sequencing run based on reagent consumption and instrument uptime. Challenge: Limited historical data for emerging technologies.
Sensitivity Analysis – related terms #
what‑if, risk assessment. A technique that evaluates how changes in input variables affect project outcomes. Example: Assessing how a 10% increase in raw material price impacts overall project NPV. Challenge: Selecting realistic ranges for variables in highly innovative projects.
Shared Services Cost – related terms #
centralized support, indirect cost. Expenses incurred for services used by multiple projects, such as IT, HR, and legal. Example: Allocating shared services cost based on headcount across three concurrent biotech programs. Challenge: Ensuring transparency and fairness in allocation.
Standard Cost – related terms #
benchmark, variance. A predetermined cost used for budgeting and performance measurement. Example: Setting a standard cost of $5 per microgram of plasmid DNA for budgeting purposes. Challenge: Updating standards as technology evolves.
Stage‑Gate Process – related terms #
phase‑review, decision point. A structured approach where projects pass through defined phases separated by gates that evaluate performance, including cost adherence. Example: A gate after pre‑clinical proof‑of‑concept that determines continuation to IND filing. Challenge: Aligning gate criteria with both scientific milestones and financial metrics.
Strategic Cost Management – related terms #
competitive advantage, value chain. The alignment of cost decisions with the organization’s long‑term strategy. Example: Investing in a proprietary cell‑line platform to reduce long‑term manufacturing costs. Challenge: Justifying upfront expenditures without immediate financial returns.
Supply Chain Cost – related terms #
logistics, procurement. Expenses related to sourcing, transporting, and storing raw materials and finished goods. Example: Budgeting $300 k for cold‑chain logistics of biologics for clinical trials. Challenge: Mitigating cost volatility due to geopolitical events.
Target Costing – related terms #
price‑to‑win, cost engineering. A methodology that starts with a market price and works backward to achieve that price by managing costs. Example: Setting a target cost of $2 per assay to remain competitive in the market. Challenge: Balancing cost reduction with regulatory compliance.
Technology Transfer Cost – related terms #
knowledge transfer, scale‑up. Expenses associated with moving a process from development to manufacturing, including documentation, training, and equipment qualification. Example: Allocating $750 k for technology transfer of a monoclonal antibody production process. Challenge: Forecasting hidden costs such as staff overtime and unexpected equipment modifications.
Time‑Phased Budget – related terms #
cash flow, schedule alignment. A budget broken down by time periods (monthly, quarterly) to match cash‑flow needs and schedule milestones. Example: A quarterly time‑phased budget for a three‑year CAR‑T cell therapy project. Challenge: Adapting the time‑phased budget when schedule changes occur.
Total Cost of Ownership (TCO) – related terms #
lifecycle costing, expense analysis. The comprehensive assessment of all costs associated with acquiring, operating, and disposing of an asset. Example: Calculating TCO for a high‑throughput sequencer, including purchase, maintenance contracts, and eventual decommissioning. Challenge: Projecting long‑term support costs for rapidly evolving platforms.
Variable Cost – related terms #
direct cost, consumption‑based. Expenses that fluctuate directly with production volume, such as reagents, consumables, and per‑batch testing. Example: Variable cost of $0.50 Per milliliter of cell‑culture media. Challenge: Predicting variable costs when batch sizes change due to scale‑up decisions.
Variance Analysis – related terms #
cost variance, performance review. The process of comparing planned versus actual performance and investigating the reasons for differences. Example: Variance analysis revealing that higher than expected labor rates caused a cost overrun. Challenge: Isolating root causes in projects with many interdependent activities.
Work Breakdown Structure (WBS) – related terms #
hierarchy, deliverable. A hierarchical decomposition of the total scope of work into manageable components. Example: A WBS that separates a vaccine project into antigen design, expression, purification, and clinical testing. Challenge: Ensuring each WBS element is linked to a cost estimate for accurate budgeting.
Zero‑Based Budgeting (ZBB) – related terms #
cost justification, incremental budgeting. A budgeting approach where each expense must be justified from scratch for each new period, rather than basing on previous budgets. Example: Performing ZBB for a fiscal year to reassess all biotech R&D expenditures. Challenge: The extensive effort required to justify every line item, especially in complex research environments.